Page last updated: 2024-09-02

ecteinascidin 743 and Asthenia

ecteinascidin 743 has been researched along with Asthenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amadio, G; Carpano, S; Ferrandina, G; Loizzi, V; Lorusso, D; Marinaccio, M; Naglieri, E; Salutari, V; Scambia, G; Tonini, G; Vincenzi, B1
Dirix, LY; Jain, MM; Jiao, JJ; Manikhas, GM; Natarajan, J; Parekh, T; Park, K; Staddon, AP; Thertulien, R; Vermorken, JB; Zannikos, P1

Trials

1 trial(s) available for ecteinascidin 743 and Asthenia

ArticleYear
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Asthenia; Dioxoles; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Single-Blind Method; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Vomiting; Young Adult

2012

Other Studies

1 other study(ies) available for ecteinascidin 743 and Asthenia

ArticleYear
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: a retrospective, multicenter study.
    Gynecologic oncology, 2013, Volume: 130, Issue:3

    Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Asthenia; Carcinoma; Dioxoles; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Platinum Compounds; Retrospective Studies; Salvage Therapy; Tetrahydroisoquinolines; Trabectedin

2013